The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Progenitor/stem cells give rise to liver cancer due to aberrant TGF-β and IL-6 signaling
Open accessAbstract
Cancer stem cells (CSCs) are critical for the initiation, propagation, and treatment resistance of multiple cancers. Yet functional interactions between specific signaling pathways in solid organ “cancer stem cells,” such as those of the liver, remain elusive. We report that in regenerating human liver, two to four cells per 30,000–50,000 cells express stem cell proteins Stat3, Oct4, and Nanog, along with the prodifferentiation proteins TGF-β-receptor type II (TBRII) and embryonic liver fodrin (ELF). Examination of human hepatocellular cancer (HCC) reveals cells that label with stem cell markers that have unexpectedly lost TBRII and ELF. elf +/− mice spontaneously develop HCC; expression analysis of these tumors highlighted the marked activation of the genes involved in the IL-6 signaling pathway, including IL-6 and Stat3, suggesting that HCC could arise from an IL-6-driven transformed stem cell with inactivated TGF-β signaling. Similarly, suppression of IL-6 signaling, through the generation of mouse knockouts involving a positive regulator of IL-6, Inter-alpha-trypsin inhibitor-heavy chain-4 (ITIH4), resulted in reduction in HCC in elf +/− mice. This study reveals an unexpected functional link between IL-6, a major stem cell signaling pathway, and the TGF-β signaling pathway in the modulation of mammalian HCC, a lethal cancer of the foregut. These experiments suggest an important therapeutic role for targeting IL-6 in HCCs lacking a functional TGF-β pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells
Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., & Smith, A. (2003) · Cell · doi:10.1016/s0092-8674(03)00392-1 · Cited by 3,255
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
Defining the Epithelial Stem Cell Niche in Skin
Tumbar, T., Guasch, G., Greco, V., Blanpain, C., Lowry, W. E., Rendl, M., & Fuchs, E. (2004) · Science · doi:10.1126/science.1092436 · Cited by 2,031
Hepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
Controlling TGF-beta signaling.
Massagué, J., & Chen, Y. (2000) · PubMed · Cited by 1,780
Massagué, J., & Chen, Y.-G. (2000) · Genes & Development · doi:10.1101/gad.14.6.627 · Cited by 1,575
Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3
Niwa, H., Burdon, T., Chambers, I., & Smith, A. (1998) · Genes & Development · doi:10.1101/gad.12.13.2048 · Cited by 1,549
Asymmetric and symmetric stem-cell divisions in development and cancer
Morrison, S. J., & Kimble, J. (2006) · Nature · doi:10.1038/nature04956 · Cited by 1,410
Fausto, N., Campbell, J. S., & Riehle, K. J. (2006) · Hepatology · doi:10.1002/hep.20969 · Cited by 1,378
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., & Akira, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3801 · Cited by 1,323
Hirano, T., Ishihara, K., & Hibi, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203551 · Cited by 1,190
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling
Lee, J.-S., Chu, I.-S., Heo, J., Calvisi, D. F., Sun, Z., Roskams, T., Durnez, A., Demetris, A. J., & Thorgeirsson, S. S. (2004) · Hepatology · doi:10.1002/hep.20375 · Cited by 922
Levy, D. E., & Lee, C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15650 · Cited by 810
Levy, D. E., & Lee, C.-K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215650 · Cited by 734
Chiba, T., Kita, K., Zheng, Y.-W., Yokosuka, O., Saisho, H., Iwama, A., Nakauchi, H., & Taniguchi, H. (2006) · Hepatology · doi:10.1002/hep.21227 · Cited by 664
Tai, M.-H. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh321 · Cited by 591
Vascular inflammation and the renin-angiotensin system
Brasier, A. R., Recinos, A., & Eledrisi, M. S. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000021412.56621.a2 · Cited by 586
Durnez, A., Verslype, C., Nevens, F., Fevery, J., Aerts, R., Pirenne, J., Lesaffre, E., Libbrecht, L., Desmet, V, & Roskams, T. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02468.x · Cited by 426
Liver stem cells and their implication in hepatocellular and cholangiocarcinoma
Roskams, T. (2006) · Oncogene · doi:10.1038/sj.onc.1209558 · Cited by 422
Disruption of Transforming Growth Factor-β Signaling in ELF β-Spectrin-Deficient Mice
Tang, Y., Katuri, V., Dillner, A., Mishra, B., Deng, C.-X., & Mishra, L. (2003) · Science · doi:10.1126/science.1075994 · Cited by 262
Self-citationLoss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-β1 production
Ogata, H., Chinen, T., Yoshida, T., Kinjyo, I., Takaesu, G., Shiraishi, H., Iida, M., Kobayashi, T., & Yoshimura, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209281 · Cited by 246
Liver Stem Cells: Implications for Hepatocarcinogenesis
Alison, M. R. (2005) · Stem Cell Reviews · doi:10.1385/scr:1:3:253 · Cited by 246
The significance of the circulating cancer cell
Salsbury, A. J. (1975) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(75)80015-6 · Cited by 197
Transforming Growth Factor-β Signaling in Stem Cells and Cancer
Mishra, L., Derynck, R., & Mishra, B. (2005) · Science · doi:10.1126/science.1118389 · Cited by 188
Self-citationFunctions of mammalian Smad genes as revealed by targeted gene disruption in mice
Weinstein, M., Yang, X., & Deng, C.-X. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00028-3 · Cited by 172
Self-citationMarkers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis
Popa, C., Netea, M. G., Radstake, T. R. D. S., van Riel, P. L., Barrera, P., & van der Meer, J. W. M. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.032243 · Cited by 167
Koomen, J. M., Shih, L. N., Coombes, K. R., Li, D., Xiao, L.-C., Fidler, I. J., Abbruzzese, J. L., & Kobayashi, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1110.11.3 · Cited by 165
The role of TGF-β and Wnt signaling in gastrointestinal stem cells and cancer
Mishra, L., Shetty, K., Tang, Y., Stuart, A., & Byers, S. W. (2005) · Oncogene · doi:10.1038/sj.onc.1208924 · Cited by 151
Self-citationWallner, L. P., Dai, J., Escara-Wilke, J. F., Zhang, J., Yao, Z., Lü, Y., Trikha, M., Nemeth, J. A., Zaki, M. H., & Keller, E. T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3447 · Cited by 148
Ray, S., Boldogh, I. R., & Brasier, A. R. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.07.055 · Cited by 139
Maione, D., Carlo, E. D., Li, W., Musiani, P., Modesti, A., Peters, M., Rose‐John, S., Rocca, C. D., Tripodi, M., Lazzaro, D., et al. (1998) · The EMBO Journal · doi:10.1093/emboj/17.19.5588 · Cited by 128
Growth characteristics of a mouse plasma cell tumor.
Bergsagel, D. E., & Valeriote, F. A. (1968) · PubMed · Cited by 108
Braun, L., Mikumo, R., & Fausto, N. (1989) · PubMed · Cited by 102
Song, J., Patel, M. J., Rosenzweig, C. N., Chan‐Li, Y., Sokoll, L. J., Fung, E. T., Choi-Miura, N.-H., Goggins, M., Chan, D. W., & Zhang, Z. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.065722 · Cited by 101
Schirmacher, P., Peters, M., Ciliberto, G., Blessing, M., Lotz, J., Büschenfelde, K. M. Z., & Rose‐John, S. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65605-2 · Cited by 100
Elf3 encodes a novel 200-kD β-spectrin: role in liver development
Mishra, L., Cai, T., Yü, P., Monga, S. P., & Mishra, B. (1999) · Oncogene · doi:10.1038/sj.onc.1202313 · Cited by 66
Self-citationKanzler, S., Meyer, E., Lohse, A. W., Schirmacher, P., Henninger, J., Galle, P. R., & Blessing, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204544 · Cited by 66
Bhanumathy, C. D., Tang, Y., Monga, S. P., Katuri, V., Cox, J. A., Mishra, B., & Mishra, L. (2001) · Developmental Dynamics · doi:10.1002/dvdy.1235 · Cited by 60
Self-citationKaturi, V., Tang, Y., Li, C., Jogunoori, W. S., Deng, C.-X., Rashid, A., Sidawy, A. N., Evans, S. R. T., Reddy, E. P., Mishra, B., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209211 · Cited by 46
Self-citationRegeneration and function of hemiliver graft: right versus left
Akamatsu, N., Sugawara, Y., Tamura, S., Imamura, H., Kokudo, N., & Makuuchi, M. (2006) · Surgery · doi:10.1016/j.surg.2005.12.011 · Cited by 31
Cited by
IL-6 in inflammation, autoimmunity and cancer
Hirano, T. (2021) · International Immunology · doi:10.1093/intimm/dxaa078 · Cited by 1,453
“The IL-6–STAT3 pathway is involved in the epithelial–mesenchymal transition (EMT) (131, 132), tumor migration (133), cancer stemness (130, 134, 135) and the induction of hypoxia-inducible factor-1 α (HIF-1 α ) and vascular endothelial growth factor (VEGF), two key players for angiogenesis (136–140).”
BackgroundNon-Smad Signaling Pathways of the TGF-β Family
Zhang, Y. E. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022129 · Cited by 697
Lee, T. K. W., Castilho, A., Cheung, V. C. H., Tang, K. H., Ma, S., & Ng, I. O. L. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.06.005 · Cited by 586
Cancer stem cells in the development of liver cancer
Yamashita, T., & Wang, X. W. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66024 · Cited by 525
Redox Regulation in Cancer: A Double‐edged Sword with Therapeutic Potential
Acharya, A., Das, I., Chandhok, D., & Saha, T. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.1.10095 · Cited by 486
Metadata
- Authors
- Tang, Y., Kitisin, K., Jogunoori, W., Li, C., Deng, C.-X., Mueller, S. C., Ressom, H. W., Rashid, A., He, A. R., Mendelson, J. S., Jessup, J. M., Shetty, K., Zasloff, M., Mishra, B., Reddy, E. P., Johnson, L., & Mishra, L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-02-19
- Volume
- 105
- Issue
- 7
- Pages
- 2445-2450
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2168472139
- Cited by
- 310
- References
- 42
- FWCI
- 13.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.